Skip to main content
BCAL
NASDAQ Finance

Shareholders Approve New Equity Incentive Plan with ~5% Potential Dilution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Bank Stocks · Financial
Sentiment info
Neutral
Importance info
7
Price
$18.97
Mkt Cap
$612.418M
52W Low
$14.07
52W High
$20.47
52W Position info
35% above low
Off High info
7.3% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

BCAL sits 35% above its 52-week low of $14.07.

Summary

California BanCorp shareholders approved a new equity incentive plan authorizing 1.6 million shares for future awards, representing approximately 5% potential dilution, and the board declared a routine quarterly cash dividend.


Key Events · Financing and Capital Events · BCAL

  • Equity Incentive Plan Approved

    Shareholders approved the 2026 Omnibus Equity Incentive Plan, authorizing 1,600,000 shares for future equity awards. This follows the proposal in the DEF 14A filed on April 14, 2026.

  • Potential Dilution

    The authorized shares represent approximately 5% of the company's current outstanding shares, creating potential future dilution if fully utilized.

  • Routine Dividend Declared

    The Board declared a quarterly cash dividend of $0.10 per share, consistent with previous declarations.

  • Annual Meeting Results

    Directors were re-elected and the independent auditor was ratified as part of routine annual meeting business.


Analysis · BCAL · Finance

Shareholders approved the 2026 Omnibus Equity Incentive Plan, authorizing the issuance of up to 1.6 million shares for future equity awards. This represents a potential dilution of approximately 5% if all authorized shares are issued, creating an overhang for existing shareholders. This approval finalizes the plan proposed in the April 14, 2026 proxy statement. Additionally, the company declared a routine quarterly cash dividend.

At the time of this filing, BCAL was trading at $18.97 on NASDAQ in the Finance sector, with a market capitalization of approximately $612.4M. The 52-week trading range was $14.07 to $20.47. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BCAL - Latest Insights

BCAL
Jul 27, 2026, 8:10 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $21.02
Real-time Price: $21.26 info
Change: +$0.240 (+1%) info
Market Cap: $683.824M info
BCAL
Jul 27, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $21.02
Real-time Price: $21.26 info
Change: +$0.240 (+1%) info
Market Cap: $683.824M info
BCAL
May 08, 2026, 4:40 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $19.25
Real-time Price: $21.26 info
Change: +$2.01 (+10%) info
Market Cap: $683.824M info
BCAL
May 08, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $19.25
Real-time Price: $21.26 info
Change: +$2.01 (+10%) info
Market Cap: $683.824M info
BCAL
May 07, 2026, 12:06 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $19.10
Real-time Price: $21.26 info
Change: +$2.16 (+11%) info
Market Cap: $683.824M info